A B S T R A C T Plasma lipoproteins of d < 1.006 g/ml, d 1.006-1.019 g/ml, and d 1.019-1.063 g/ml from patients with familial lecithin: cholesterol acyltransferase deficiency yielded abnormal subfractions upon being separately filtered through 2% agarose gel. A subfraction that emerged with the void volume and contained unusually large amounts of unesterified cholesterol and phosphatidylcholine was present in each lipoprotein group, and in each group this subfraction was less prominent in the nonlipemic plasma of one patient than in the lipemic plasma of other patients. A subfraction containing smaller lipoproteins also was present in each lipoprotein group. These lipoproteins were of the same size as normal lipoproteins of the corresponding density, but contained abnormally small amounts of cholesteryl ester. The lipoproteins of 1.019-1.063 g/ml contained abnormal components of intermediate molecular weight as well as large and small abnormal components similar to those described previously. The intermediate components were more prominent in the nonlipemic plasma but were easily recognized in the hyperlipemic plasma as a peak of Sf 20-30 in the analytical ultracentrifuge. Also they could be recognized, upon electron microscopy of the lipoproteins of d 1.019-1.063 g/ml, as particles 340-1000 A in diameter.
INTRODUCTION
Human plasma contains an enzyme that can catalyze formation of cholesteryl esters by transferring fatty acids from the lecithin (phosphatidylcholine [PC])1 to the unesterified cholesterol (UC) of high density lipoproteins (HDL). Although this lecithin: cholesterol acyltransferase (LCAT) appears to form most of the cholesteryl esters (CE) of human plasma lipoproteins (1, 2) , its physiological role remains to be clarified. Thus, it is not clear why more than two-thirds of the plasma cholesterol is esterified nor why most of the (4) (5) (6) have been discovered in Scandinavia. The relative content of CE in the plasma of these patients is grossly abnormal, and cannot be explained on the basis of endocrine or nonspecific hepatic dysfunction (7) . Consequently, the patients provide a new vantage point from which to study plasma cholesterol metabolism in general and the role of the LCAT reaction in particular. Several investigators, whose work has recently been reviewed (7, 8) , have been attempting to characterize the patients' various abnormalities. Our group is currently studying the composition and physical properties of the plasma lipoproteins in order to define the abnormalities and provide a base line for subsequent metabolic studies. Already, several lipoprotein abnormalities have been uncovered. For example, each of the six patients studied has very low density lipoproteins (VLDL) that migrate abnormally on electrophoresis (7) ; five patients have hyperlipemia (7); the four patients whose low density lipoprotein (LDL) lipids have been measured (9, 10) have increased concentrations of LDL unesterified cholesterol and lecithin in the plasma; and studies (10, 11) abnormalities associated with the hyperlipemia from those more directly associated with the enzyme lack by comparing lipoproteins from the nonlipemic plasma of one patient with those from the hyperlipemic patients. A final aim was to determine whether abnormal large and small LDL of d 1.019-1.063 g/ml, similar to those described previously (10, 11) , are present in the plasma of additional patients.
METHODS
The two patients studied in most of the experiments were M. R., a 23-yr old nonlipemic female, and L. G., a 38-yr old lipemic male. Other patients were I. S., the 34-yr old lipemic sister of M. R., and A. A., the previously studied (10, 11) lipemic sister of L. G. The clinical features, pertinent laboratory findings, and some of the plasma lipoprotein abnormalities of these patients have been described previ-= ously (4, 5, 7) . None of the patients was obese or showed signs of thyroid, pancreatic, or nonspecific hepatic dysfunction at the time of study. All had slightly reduced concentrations of serum albumin (less than 4, but more than 3 g/ml serum) and moderately increased concentrations of urine protein (0.5-1.5 mg/ml urine). Control subjects were normal females aged 22-35 yr. Neither patients nor control subjects received special diets or medication in connection with the studies, although blood was withdrawn after they had fasted overnight.
Acid citrate dextrose solution (U. S. P. formula A) was used as anticoagulant, blood cells were separated in a refrigerated centrifuge, and p-chloromercuriphenylsulfonate (PCMPS) was added to a final concentration of 2 mM to facilitate comparison with previous experiments. Lipoproteins were fractionated by preparative ultracentrifugation, washed twice by recentrifugation using the same conditions, and analyzed for lipid and protein as described previously (9) . Tables I and II show the lipid compositions of the major lipoprotein classes of M. R., I. S., and L. G. at the time of study. The concentrations of the lipids of M. R. were very similar to those reported previously (9) . Note that the triglyceride (TG) of the lipoproteins of d < 1.006 g/ml was elevated in the plasma of I. S. and L. G., but not in that of patient M. R.
The lipoproteins of d < 1.006 g/ml were subfractionated on columns of 2% agarose gel (Bio-Gel A 50m, 100-200 mesh, Bio-Rad Laboratories, Richmond, Calif.); equilibrated and eluted with 0.15 N NaCl-1.0 mM EDTA, pH 7.4 . Protein in the effluent was measured using a modification (12) of the method of Lowry or using the method of Hirs (13) (14) . However, we cannot be sure that breakdown of the lipoproteins did not occur followed by preferential retention of the lipid since we could detect no certain difference in the small amount of protein recovered in association with the larger lipoproteins. In view of the evidence of adsorption or selective retention by the agarose gel, a given column was used for portions of one preparation only, and the gel was subsequently discarded. Subfractionation of the LDL of d 1.019-1.063 g/ml by gel filtration through 2% agarose gel and analytical ultracentrifugation were done as described previously (10) . Lipoprotein subfractions obtained in the gel filtration experiments were concentrated by ultrafiltration through Diaflow filters (PM-10; Amicon Corp., Lex- ington, Mass.).
Electron microscopy was usually performed on samples not more than 1 wk after they had been prepared. Portions were dialyzed against ammonium acetate-ammonium carbonate buffer (15) , mixed with an equal volume of 2%o sodium phosphotungstate, pH 7.4, and examined on a Formvar/carbon-coated grid as described previously (11 Material corresponding to that present in 73 ml plasma (24.3 mg lipoprotein protein) filtered through a 4.5 X 150 cm column of 2% agarose gel. Note that the "absorbance" of the void volume lipoproteins was mainly light scattering. Effluent corresponding to areas labeled "L" and "S" pooled for analysis (see Table III ). Recovery of applied lipoprotein cholesterol was 93%. Section B shows lipoproteins of patient I. S. Material corresponding to that present in 25.5 ml plasma (9.5 mg lipoprotein protein) filtered through a 4.5 X 150 cm column of 2% agarose gel. Effluent pooled as in A. Note that the void volume peak obtained with the lipoproteins of L. G. has a shoulder whereas the corresponding peak obtained with the lipoproteins of I. S. does not, and that we have no explanation for this difference. Note also that in the experiment shown in B the recovery of applied lipoprotein cholesterol was only 62%o, and that lipoproteins in concentrations too low to be detected by absorbance measurements may have been eluted after the cut off volume that defines subfraction "S."
average of 0.68 imol CE/mg protein, whereas the corresponding value for normal VLDL was 1.30 Amol CE/ mg protein. In contrast, the same VLDL of A. R. contained an average of 1.75 Amol PC/mg protein whereas the normal VLDL contained 1.06 jumol PC/mg protein.
The VLDL of L. G. and I. S. appeared to share the same abnormality as indicated by the relative compositions of the large and small molecular weight subfractions (Table  IV) . (10) . The LDL of L. G. (Fig. 4 A) , like those of two other hyperlipemic patients, I. S. (Fig. 5) Tables V-VIII . The large LDL of L. G. and M. R. respectively contained 9.5 and 13% of the total LDL protein of d 1.019-1.063 g/ml. In contrast, the intermediate LDL of the two patients respectively contained 29 and 36.9% of the total. The remainder, at least half of the total, was in the small molecular weight subfraction, Plasma Lipoproteins in Familial LCAT Deficiency L. G. and I. S. contained less CE relative to UC or TG than those of M. R., and the large molecular weight subfractions from the plasma of L. G. and I. S. contained three to five times as much lipid relative to protein as those from the plasma of M. R.
Analytical ultracentrifugation. Several of the lipoprotein fractions and subfractions from the plasma of L. G. (Fig. 7) and MI. R. (Fig. 8) were analyzed by analytical ultracentrifugation. Fig. 7A shows the ultracentrifugal distribution obtained for the unsubfractionated lipoproteins of d < 1.063 g/ml of L. G. In addition to a vo 300 400 Volume ( ml) FIGURE 3 Subfractionation of LDL of d 1.006-1.019 g/ml by filtration through 2% agarose. Section A shows results of analysis of LDL from same control plasma used in the experiment shown in Fig. 2 although in absolute terms, the concentration of protein in this subfraction was only 23% of that of corresponding normal LDL (see Table I ). Fig. 4A were refiltered through the same column. Section B shows refiltration of subfractions corresponding to areas labeled "I" in section A. Section C shlows two separate refiltration experiments with pooled subfractions corresponding to areas of the filtration diagram in section A labeled "L" and "S," respectively. lipoproteins of L. G. shown in Fig. 4 Electron microscopy. Figs. 9 and 10 show electron micrographs of the large, intermediate, and small molecular weight LDL subfractions from patients L. G. and M. R. The large molecular wveight LDL from both patients consist of particles which, for the most part, are greater than 1000 A in size. Occasionally the negative stain can be seen penetrating into the very large particles so that myelin figures are produced (Fig. 9A ).
Flattening and aggregation of the particles makes it difficult to determine whether there is a difference in size distribution between the large molecular weight LDL in the two patients.
The intermediate molecular weight subfractions of both subjects (Figs. 9 B and 10 B) show two distinct populations of particles. In each case the smaller of these consists of round particles 170-340 A in diameter which is consistent with the dimensions of the small molecular weight LDL described previously (11) . The small particles thus presumably represent contaminating small molecular weight components. The larger particles of intermediate molecular weight LDL consist of electron transparent structures which appear to be flattened and occasionally form arrays of stacked particles (Fig. 9 B The low molecular weight LDL subfractions from both L. G. (Fig. 9 C) and WI. R. (Fig. 10 C) The rate of flotation of lipoproteins in a centrifugal field is not only influenced by density, but also by molecular size.
The fact that some of the patients' LDL of densities within the relatively narrow range of 1.019-1.063 g/ml float at rates in excess of Sf 12 indicates therefore that very large particles are present. (Figs. 4 and 6) .
If the large lipoproteins are not artifacts, how are they formed and why are they particularly abundant in the lplasma of the hvperlipemic patients ? Neither question can be answered (lefinitively.. However, dietary experiments (Glomset, Norum, Nichols, King, Mitchell, Applegate, andl Gjone, to be published) have shown that the concentrations of the large lipoproteins all diminish markedly and disproportionately when the patients consume fat-free diets. This is compatible with the postulate of Schumaker and Adams (3) that a normal function of the LCAT reaction is to dispose of the surface UJC and PC of large, TG-rich lipoproteins, once the TG has been hydrolyzed by lipoprotein lipase. Thus, the large lipoproteins might be formed from surface "remnant" UC, PC, and protein in the absence of the normal disposal mechanism. If this occurs, increased turnover of plasma TG might promote accumulation of the large lipoproteins in the patients' plasma and thus account for the increased concentrations of these UC-and PC-rich components in the plasma of L. G. and I. S. However, substantiation of this possibility will hlave to await further studies. At present our only reason for believing that the turnover of plasma TG may be increased in the hyperlipemic patients is the still tenuous association between the renal component of familial LCAT deficiency and the hyperlipemia. Although none of the patients studied here has the nephrotic syndrome, all have moderate proteinuria, and A. R., the sister of M. R., did develop the nephrotic syndrome. Of most significance, however, is the fact that the plasma TG of A. R. increased as her renal function deteriorated, then decreased to almost normal as all renal function ceased, and has since remained low during treatment by dialysis (E. Gjone, unpublished observations).
In our previous study (10) (16, 17) and of patients with cholestasis (18, 19) . They emerge from columns of 2% agarose gel in the same general position (16, 20) , have similar flotation properties (17, 19) , and negatively stained preparations have the same general appearance upon electron microscopy (16, 18 (23) (24) (25) (26) . Therefore, the abnormalities of the patients' lipoproteins of this density are best shown by our analyses of the successive subfractions obtained upon gel filtration of the lipoproteins of M. R. (Fig. 2) . Com- parison of the spectrum of her lipoproteins of d < 1.006 g/ml with that of corresponding normal lipoproteins showed two abnormalities: (a) the relative content of CE was essentially constant, and (b) the relative content of PC increased with increasing elution volume.. The most likely explanation of these abnormalities is that normal VLDL are progressively converted into smaller lipoproteins by the simultaneous action of several enzymes, one of which is LCAT. Evidence has already been reported (27, 28, 9) that LCAT indirectly increases the CE and decreases the TG, UC, and PC of VLDL in vitro. Also, we have found (29) that LCAT increases the mobility of the patients' VLDL, and that this is associated with in vitro fragmentation of the VLDL into LDL (Norum, Glomset, Nichols, Forte, King, Applegate, Mitchell, and Albers, to be published). In the absence of LCAT, one might therefore expect abnormalities with regard to the lipid composition of VLDL. Similarly, since LCAT increases the CE and decreases the TG, UC, and PC of the patients' unsubfractionated LDL (9) , one would expect that any normalsized LDL generated during the catabolism of VLDL (30, 31) , in the absence of LCAT, would contain abnormally high amounts of TG, UC, and PC, and abnormally low amounts of CE.
Two postulates concerning the patients' abnormal lipoproteins of d < 1.063 g/ml are schematically summarized by Fig. 11 . The heavily shaded arrow represents a metabolic pathway, similar to one that appears to exist in normal plasma (30, 31) , by which VLDL are progressively converted into smaller VLDL and LDL of d 1.006-1.019 g/ml and d 1.019-1.063 g/ml. We suggest that the patients' smaller VLDL and LDL are formed by this pathway since they are essentially normal in size and in relative protein content, and since the ratio of "surface" lipid to "core" lipid (PC + S + UC/TG + CE) is nearly normal. However, since the concentration of the small LDL is low and the CE content abnormal, fragmentation of the VLDL and replacement of the "core" TG of the VLDL and LDL by exchange with HDL CE are probably reduced. In contrast to the heavily shaded arrow, the lightly stippled arrow represents an abnormal pathway caused by deficient removal of the surface UC and PC of chvlomicrons and large VLDL, once the triglyceride of these lipoproteins has been hydrolyzed by lipoprotein lipase. In the absence of LCAT this excess lipid spontaneously dissociates from the surfaces of these lipoproteins and forms bilayers which form variously sized, large aggregates depending on the amount of apoprotein present.
